JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB129732

Resazurin Assay Kit (Cell Viability)

Be the first to review this product! Submit a review

|

(25 Publications)

Resazurin Assay Kit ab129732 is a fluorometric/colorimetric assay used to measure the metabolic capacity of live cells.

- Fluorescent readout - use with standard microplate reader
6 Images
Functional Studies - Resazurin Assay Kit (Cell Viability) (AB129732)
  • FuncS

Supplier Data

Functional Studies - Resazurin Assay Kit (Cell Viability) (AB129732)

Jurkat cells were seeded at 25,000 cells per well in a 50 μL volume and immediately overlayed with a 2X concentration of the indicated drug for a final volume of 100 μL. Cells were incubated for 2 hours with the indicated drug prior to the addition of 2X stain diluted in RPMI media. After 4 hours of further incubation with stain, fluorescence was measured. IC50 for the indicated drug was found at 22 – 25 μM.

Functional Studies - Resazurin Assay Kit (Cell Viability) (AB129732)
  • FuncS

Supplier Data

Functional Studies - Resazurin Assay Kit (Cell Viability) (AB129732)

Dynamic range and suitability of the mitochondrial viability assay for high throughput screening. Cells were seeded in a titration series with n=11 for each data point. Fluorometric readout gave on average a Z factor of 0.82 on Jurkat cells seeded from 1,500 – 1000,000 cells per well on a 96-well plate.

Functional Studies - Resazurin Assay Kit (Cell Viability) (AB129732)
  • FuncS

Supplier Data

Functional Studies - Resazurin Assay Kit (Cell Viability) (AB129732)

Mitochondrial viability stain in long term toxicity. HepG2 cells previously cultured in glucose or galactose substrate media were seeded at 10,000 cells per well and allowed to adhere overnight. Media was replaced for the specific culture media in the presence of a titration series of Rotenone (5 µM – 0.5 pM). Cells were treated for 72 hours prior to the addition of 2X stain. After 4 hours of incubation plates were analyzed by fluorescent readout.

Functional Studies - Resazurin Assay Kit (Cell Viability) (AB129732)
  • FuncS

Supplier Data

Functional Studies - Resazurin Assay Kit (Cell Viability) (AB129732)

Dynamic range and suitability of the mitochondrial viability assay for high throughput screening. Cells were seeded in a titration series with n=11 for each data point. Colorimetric readout gave on average a Z factor of 0.72 on HepG2 cells seeded from 40,000 – 150,000 cells per well.

Functional Studies - Resazurin Assay Kit (Cell Viability) (AB129732)
  • FuncS

Supplier Data

Functional Studies - Resazurin Assay Kit (Cell Viability) (AB129732)

Jurkat cells were seeded at 25,000 cells per well in a 50 µL volume and immediately overlayed with a 2X concentration of Staurosporin for a final volume of 100 µL. Cells were incubated for 4 hours with Staurosporin prior to the addition of 2X stain diluted in RPMI media. After 4 hours of further incubation with stain, fluorescence was measured. IC50 for staurosporin was found at 500 nM.

Functional Studies - Resazurin Assay Kit (Cell Viability) (AB129732)
  • FuncS

Supplier Data

Functional Studies - Resazurin Assay Kit (Cell Viability) (AB129732)

Effect of stain incubation time on assay reproducibility and background. Dark wall plates were seeded with a titration series of each cell line in a final volume of 100 µL of media. 2X stain (diluted in the cell line specific growth media) was added to each well at specified time points. XY graphs data is shown after media and background substraction. Bar graph shows mean background staining at different time points. 4 hour incubation of stain results in optimal reproducibility with minimal increase of background over the 2 hour incubation.

Key facts

Detection method

Fluorescent

Sample types

Suspension cells, Adherent cells

Assay type

Cell-based

Results type

Quantitative

Assay Platform

Microplate reader

Product details

Resazurin Assay Kit ab129732 is a fluorometric/colorimetric assay used to measure the metabolic capacity of live cells.

The resazurin assay is commonly used to quantify the number of live cells in a sample, and to monitor cell viability / cytotoxicity. It is a fast, simple, accurate and homogeneous / no-wash high throughput assay that can be used to monitor cells for up to 24-48 hours.

The resazurin assay protocol is based on the reduction of oxidized non-fluorescent blue resazurin to a red fluorescent dye (resorufin) by the mitochondrial respiratory chain in live cells. The amount of resorufin produced is directly proportional to the number of living cells. Resorufin has Ex/Em of 530-560 / 590 nm and absorbance at absorbance at 570nm.

The resazurin dye can be measured in fluorescence or absorbance mode. However fluorescence mode measurement offers greater assay linearity, reproducibility, robustness and sensitivity.

Resazurin assay protocol summary:
- add resazurin reagent to cells in growth media and incubate for 4 hr at 37°C
- analyze with microplate reader

Explore our curated range of easy-to-use, efficient and fast cell viability assays.

This kit was previously called Mitochondrial Viability Stain. Review our cell health assay guide to learn about our kits to perform a cell viability assay, cytotoxicity assay or cell proliferation assay.

What's included?

{ "values": { "2000Test": { "sellingSize": "2000 Test", "publicAssetCode":"ab129732-2000Test", "assetComponentDetails": [ { "size":"1 x 24 mL", "name":"20X Cell Viability Stain", "number":"AB129732-CMP01", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
+4°C

Product protocols

Publications (25)

Recent publications for all applications. Explore the full list and refine your search

Heliyon 11:e41295 PubMed39831163

2025

Leveraging RIBOTAC technology: Fluorescent RNase L probes for live-cell imaging and function analysis.

Applications

Unspecified application

Species

Unspecified reactive species

Elias Khaskia,Raphael I Benhamou

PLoS biology 22:e3002767 PubMed39316623

2024

A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist.

Applications

Unspecified application

Species

Unspecified reactive species

Jérémie Le Pen,Gabrielle Paniccia,Volker Kinast,Marcela Moncada-Velez,Alison W Ashbrook,Michael Bauer,H-Heinrich Hoffmann,Ana Pinharanda,Inna Ricardo-Lax,Ansgar F Stenzel,Edwin A Rosado-Olivieri,Kenneth H Dinnon,William C Doyle,Catherine A Freije,Seon-Hui Hong,Danyel Lee,Tyler Lewy,Joseph M Luna,Avery Peace,Carltin Schmidt,William M Schneider,Roni Winkler,Elaine Z Yip,Chloe Larson,Timothy McGinn,Miriam-Rose Menezes,Lavoisier Ramos-Espiritu,Priyam Banerjee,John T Poirier,Francisco J Sànchez-Rivera,Aurélie Cobat,Qian Zhang,Jean-Laurent Casanova,Thomas S Carroll,J Fraser Glickman,Eleftherios Michailidis,Brandon Razooky,Margaret R MacDonald,Charles M Rice

Cancer discovery 14:1838-1859 PubMed38916500

2024

Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk.

Applications

Unspecified application

Species

Unspecified reactive species

Shunsuke Kimura,Chun Shik Park,Lindsey E Montefiori,Ilaria Iacobucci,Petri Pölönen,Qingsong Gao,Elizabeth D Arnold,Andishe Attarbaschi,Anthony Brown,Barbara Buldini,Kenneth J Caldwell,Yunchao Chang,Chelsey Chen,Cheng Cheng,Zhongshan Cheng,John Choi,Valentino Conter,Kristine R Crews,Hester A de Groot-Kruseman,Takao Deguchi,Mariko Eguchi,Hannah E Muhle,Sarah Elitzur,Gabriele Escherich,Burgess B Freeman,Zhaohui Gu,Katie Han,Keizo Horibe,Toshihiko Imamura,Sima Jeha,Motohiro Kato,Kean H Chiew,Tanya Khan,Michal Kicinski,Stefan Köhrer,Steven M Kornblau,Rishi S Kotecha,Chi-Kong Li,Yen-Chun Liu,Franco Locatelli,Selina M Luger,Elisabeth M Paietta,Atsushi Manabe,Hanne V Marquart,Riccardo Masetti,Mellissa Maybury,Pauline Mazilier,Jules P P Meijerink,Sharnise Mitchell,Takako Miyamura,Andrew S Moore,Koichi Oshima,Katarzyna Pawinska-Wasikowska,Rob Pieters,Mollie S Prater,Shondra M Pruett-Miller,Ching-Hon Pui,Chunxu Qu,Michaela Reiterova,Noemi Reyes,Kathryn G Roberts,Jacob M Rowe,Atsushi Sato,Kjeld Schmiegelow,Martin Schrappe,Shuhong Shen,Szymon Skoczeń,Orietta Spinelli,Jan Stary,Michael Svaton,Masatoshi Takagi,Junko Takita,Yanjing Tang,David T Teachey,Paul G Thomas,Daisuke Tomizawa,Jan Trka,Elena Varotto,Tiffaney L Vincent,Jun J Yang,Allen E J Yeoh,Yinmei Zhou,Martin Zimmermann,Hiroto Inaba,Charles G Mullighan

Osteoarthritis and cartilage 32:1084-1096 PubMed37935325

2023

Phenotype and energy metabolism differ between osteoarthritic chondrocytes from male compared to female patients: Implications for sexual dimorphism in osteoarthritis development?

Applications

Unspecified application

Species

Unspecified reactive species

Lekha Jain,Caitlin A Jardim,Richard Yulo,Scott M Bolam,A Paul Monk,Jacob T Munro,Rocco Pitto,Jade Tamatea,Nicola Dalbeth,Raewyn C Poulsen

Marine life science & technology 5:94-101 PubMed37073329

2023

Identification of marine natural product Pretrichodermamide B as a STAT3 inhibitor for efficient anticancer therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Rui Li,Yue Zhou,Xinxin Zhang,Lujia Yang,Jieyu Liu,Samantha M Wightman,Ling Lv,Zhiqing Liu,Chang-Yun Wang,Chenyang Zhao

Nature genetics 54:637-648 PubMed35513723

2022

CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk.

Applications

Unspecified application

Species

Unspecified reactive species

Constance Baer,Shunsuke Kimura,Mitra S Rana,Andrew B Kleist,Tim Flerlage,David J Feith,Peter Chockley,Wencke Walter,Manja Meggendorfer,Thomas L Olson,HeeJin Cheon,Kristine C Olson,Aakrosh Ratan,Martha-Lena Mueller,James M Foran,Laura J Janke,Chunxu Qu,Shaina N Porter,Shondra M Pruett-Miller,Ravi C Kalathur,Claudia Haferlach,Wolfgang Kern,Elisabeth Paietta,Paul G Thomas,M Madan Babu,Thomas P Loughran,Ilaria Iacobucci,Torsten Haferlach,Charles G Mullighan

Frontiers in physiology 13:885545 PubMed35492615

2022

Protective Effect of Purinergic P2X7 Receptor Inhibition on Acrolein-Induced Urothelial Cell Damage.

Applications

Unspecified application

Species

Unspecified reactive species

Zhinoos Taidi,Kylie J Mansfield,Hafiz Sana-Ur-Rehman,Kate H Moore,Lu Liu

Pharmaceuticals (Basel, Switzerland) 14: PubMed34959691

2021

Acquired Drug Resistance Enhances Imidazoquinoline Efflux by P-Glycoprotein.

Applications

Unspecified application

Species

Unspecified reactive species

Anunay J Pulukuri,Anthony J Burt,Larissa K Opp,Colin M McDowell,Maryam Davaritouchaee,Amy E Nielsen,Rock J Mancini

Scientific reports 11:968 PubMed33441836

2021

Adenosine A2A receptor signaling promotes FoxO associated autophagy in chondrocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Benjamin Friedman,Carmen Corciulo,Cristina M Castro,Bruce N Cronstein

International journal of molecular sciences 21: PubMed32575737

2020

Effect of SOX2 Repression on Corneal Endothelial Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jin Sun Hwang,Ho Chul Yi,Young Joo Shin
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com